Shanghai OPM Biosciences Revenue

Shanghai OPM Biosciences had revenue of 93.78M CNY in the quarter ending September 30, 2025, with 29.80% growth. This brings the company's revenue in the last twelve months to 352.91M, up 22.84% year-over-year. In the year 2024, Shanghai OPM Biosciences had annual revenue of 297.24M with 22.26% growth.

Revenue (ttm)

352.91M

Revenue Growth

+22.84%

P/S Ratio

18.36

Revenue / Employee

5.51M

Employees

328

Market Cap

6.48B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	297.24M	54.12M	22.26%
Dec 31, 2023	243.12M	-51.24M	-17.41%
Dec 31, 2022	294.37M	81.68M	38.41%
Dec 31, 2021	212.68M	87.71M	70.19%
Dec 31, 2020	124.97M	66.45M	113.55%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Huadong Medicine	43.09B
WuXi AppTec	43.07B
Yunnan Baiyao Group Co.,Ltd	40.77B
Shanghai Fosun Pharmaceutical (Group)	39.55B
Shenzhen Mindray Bio-Medical Electronics	33.07B
Jiangsu Hengrui Medicine	30.98B
Zhejiang NHU Company	22.47B
Aier Eye Hospital Group	22.17B

Revenue Rankings